Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevation Oncology (ELEV), Novartis AG (Six Swiss: CH:NOVN) and VBI Vaccines (VBIV)
TipRanksJul 19, 2023 17:04
Raymond James Maintains Outperform on VBI Vaccines, Lowers Price Target to $6
BenzingaApr 13, 2023 21:25
Raymond James Cuts Price Target on VBI Vaccines to $6 From $60, Maintains Outperform Rating
MT NewswiresApr 13, 2023 20:47
VBI Vaccines Analyst Ratings
Benzinga Analyst RatingsNov 11, 2022 19:42
Raymond James Downgrades VBI Vaccines to Outperform, Lowers Price Target to $2
Benzinga Real-time NewsNov 11, 2022 19:41
No Data
No Data